NHS launches ‘game-changing’ guide to tackle problematic polypharmacy ‘The mechanics of tackling overprescribing and problematic polypharmacy’ is aimed to provide “practical, evidence-based strategies” to cut overprescribing.…
Our team saves £1m per year on medicines in East Kent by keeping a close eye on value The medicines value team at East Kent Hospitals University NHS Foundation Trust is keeping sustainability in mind while continuing to meet annual savings targets of £1m on the trust’s medicines bill.…
NICE recommends once-weekly injection for severe blood clotting disorder Efanesoctocog alfa, a once-weekly treatment for patients with severe haemophilia A, removes the need for frequent dosing, owing to its effective bleeding control.…
Use community pharmacies to combat falling vaccine uptake, report urges A report published by the Company Chemists’ Association on behalf of the Pharmacy Vaccinations Development Group has suggested that community pharmacies are well placed to increase vaccine uptake, raise patients’ confidence and prevent ill health.…
Whooping cough cases increase by 1,600% in a year, data show Data from the UK Health Security Agency show that in 2024, the total number of pertussis cases exceeded the total cases observed during the 2012 whooping cough outbreak in England.…
First non-cannabis treatment for rare form of epilepsy made available on NHS Fenfluramine is a non-cannabis treatment for patients with Lennox-Gastaut syndrome who do not respond to existing treatments or clobazam owing to its side effects.…
ICBs may commission community pharmacies to offer diabetic eye screenings from 2026, says NHS England NHS England has proposed a diabetic eye screening programme that could be commissioned from community health centres, high street opticians and pharmacies to accommodate local community needs.…
Inclisiran prescribed to 7% of expected target population in three years, NHS data reveal Exclusive: The Royal College of General Practitioners and the British Medical Association maintain that caution should be taken when prescribing inclisiran since long-term trial data on the drug will not be available until 2026.…
Inhaler return to pharmacies part of updated NHS ‘Green plan guidance’ The updated guidance encourages trusts and other NHS organisations to renew their sustainability plans for the next three-year cycle in order to help achieve NHS net zero carbon emissions.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…
